Literature DB >> 8465412

HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections.

L Gradoni1, A Scalone, M Gramiccia.   

Abstract

Twenty-two sera from visceral leishmaniasis (VL) patients with human immunodeficiency virus (HIV) infection (50% with the acquired immune deficiency syndrome) were examined for anti-Leishmania immunoglobulin G (IgG) antibodies and compared with 35 sera from VL patients without HIV (controls). Significant titres of specific IgG were found in 81.8% of co-infections. However, while control sera showed a restricted range of anti-Leishmania IgG titres, sera from co-infection cases displayed a considerable degree of variability, both quantitative and qualitative. They were clearly divided into 2 groups: one (18 sera) showing a continuous grading from nil to mid-concentrations of specific antibodies, the other (3 sera) showing titres 30-fold higher than this range. Taking into account the major immunological abnormalities involving humoral response described in HIV patient, the 2 groups may reflect a different sequence of acquisition of the 2 infective agents; the former representing VL acquired after HIV infection, and the latter representing the contrary situation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465412     DOI: 10.1016/0035-9203(93)90441-r

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  13 in total

1.  [Cutaneous leishmaniasis].

Authors:  E von Stebut; C Sunderkötter
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

2.  Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  P Salotra; G Sreenivas; G P Pogue; N Lee; H L Nakhasi; V Ramesh; N S Negi
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing.

Authors:  L Gradoni; R Pizzuti; L di Martino; M Gramiccia; R Pempinello; G B Gaeta; M Ferrara; S Scotti; S Altieri
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

5.  Visceral leishmaniasis in a child with HIV-1 infection.

Authors:  A Guarino; A Castaldo; L Di Martino; A Rubino; G B Gaeta; L Gradoni
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

6.  PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs.

Authors:  A Mathis; P Deplazes
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.

Authors:  Sandeep Verma; Rajesh Kumar; Gajendra Kumar Katara; Laishram Chandreshwor Singh; Narender Singh Negi; V Ramesh; Poonam Salotra
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

Review 8.  The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis.

Authors:  Gláucia Fernandes Cota; Marcos Roberto de Sousa; Fábio Nogueira Demarqui; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

9.  Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country.

Authors:  Trentina Di Muccio; Aldo Scalone; Antonella Bruno; Massimo Marangi; Romualdo Grande; Orlando Armignacco; Luigi Gradoni; Marina Gramiccia
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 10.  Visceral leishmaniasis and HIV coinfection: current perspectives.

Authors:  José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz
Journal:  HIV AIDS (Auckl)       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.